REG - Dunelm Group plc - Director/PDMR Shareholding

DunelmAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250617:nRSQ0763Na&default-theme=true

RNS Number : 0763N  Dunelm Group plc  17 June 2025

17 June 2025

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS EXERCISING MANAGERIAL
RESPONSIBILITY AND CONNECTED PERSONS

 

Dunelm Group plc (the "Company") has been notified that on 16 June 2025, Karen
Witts, Chief Financial Officer, exercised 51,496 nil cost options over
ordinary shares of one pence each in the Company. These options were granted
to her on 9 June 2022 under the terms of the Dunelm Group 2014 Long Term
Incentive Plan. Ms Witts has sold 24,277 ordinary shares at a price of
£11.78p per share to fund the tax and national insurance due in connection
with this exercise.

 

For further information please contact:

 Dunelm Group plc

 Luisa Wright/Simon Hockridge     InvestorRelations@dunelm.com (mailto:InvestorRelations@dunelm.com)

 MHP Communications
 Rachel Farrington/Charles Hirst  dunelm@mhpgroup.com (mailto:dunelm@mhpgroup.com)

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Karen Witts

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Dunelm Group plc

 b)   LEI                                                          213800WCOWEI3T5DUV19

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of one pence each

      Identification code

                                                                   ISINGB00BICQ739

 b)   Nature of the transaction                                    1.   Exercise of nil cost options under the Long-Term Incentive Plan

                                                                   2.   Sale of shares to fund income tax and national insurance liability on

                                                            exercise of such award

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   Nil       Exercise of options: 51,496
                                                                   £11.78    Shares sold: 24,277

 

 d)   Aggregated information

      - Aggregated volume                                          1.   51,496

                                                                   2.   24,277

1.   Nil
      - Price

                                                            2.   £11.78

 e)   Date of the transaction                                      2025.06.16

 f)   Place of the transaction                                     1.   Outside a trading venue

                                                                   2.   London Stock Exchange (XLON)

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

1.   51,496

2.   24,277

1.   Nil

2.   £11.78

e)

 

Date of the transaction

 

 

2025.06.16

f)

 

Place of the transaction

 

 

1.   Outside a trading venue

2.   London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPKABKCBKDPAD